Harry Skip Kiil

CIK 1708062 · EVP & President Cardiovascular · last filed 2026-09-17

Harry Skip Kiil is an EVP & President Cardiovascular who has filed 14 SEC Form 4 insider transactions across 1 company since 2025. The most recent filing shows the insider sold $138.9K of MDT on Sep 17, 2026. Across all open-market trades the lifetime net is −$6.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $3.6M across reported positions. 13 SEC filings were submitted jointly with Medtronic plc.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$3.64M

Companies

Total Filings

Lifetime Open-Market Net

-$6.40M

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

Filer Profile

Reported Address

7475 LUSK BLVD.
SAN DIEGO, CA 92121

Related Filers

Medtronic plc — 13 joint filings, latest 2026-08-04

Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
MDT	EVP & President Cardiovascular	42,186	$86.38	$3.64M	-$6.40M	10	2026-09-17

Recent Filings

14 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2026-09-17	MDT	Sell (S)	−1,483	-$138.9K	EDGAR
2026-09-16	MDT	Notice (144)	−1,483	-$138.9K	EDGAR
2026-08-04	MDT	Mixed	+6,156	-$262.5K	EDGAR
2026-06-09	MDT	Sell (S)	−4,189	-$337.0K	EDGAR
2026-06-08	MDT	Notice (144)	−4,189	-$337.0K	EDGAR
2026-06-08	MDT	Tax (F)	−6,817	-$568.0K	EDGAR
2026-05-28	MDT	Exer (M)	+15,195	$0	EDGAR
2026-02-26	MDT	Mixed	−1,648	-$507.7K	EDGAR
2026-02-19	MDT	Notice (144)	−52,524	-$5.13M	EDGAR
2025-12-09	MDT	Tax (F)	−1,702	-$172.5K	EDGAR

Showing 1–10 of 14

Page 1 of 2 Next

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.